Alembic Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 40.50 Cr
as on 12-11-2024
- Paid Up Capital ₹ 39.31 Cr
as on 12-11-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 600.00 Cr
as on 12-11-2024
- Satisfied Charges ₹ 219.36 Cr
as on 12-11-2024
- Revenue 1.30%
(FY 2023)
- Profit -36.21%
(FY 2023)
- Ebitda -26.90%
(FY 2023)
- Net Worth -16.56%
(FY 2023)
- Total Assets -13.34%
(FY 2023)
About Alembic Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 533573 and on the National Stock Exchange(NSE) under APLLTD.
The Corporate was formerly known as Alembic Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.50 Cr and a paid-up capital of Rs 39.31 Cr.
The company currently has active open charges totaling ₹600.00 Cr. The company has closed loans amounting to ₹219.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Alembic Pharmaceuticals Limited India are Chirayu Amin as Ceo, R Baheti as Cfo, and Manisha Kathed as Company Secretary. Archana Hingorani, Manish Kejriwal, Chirayu Amin, and Five other members serve as directors at the Company.
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alembic Pharmaceuticals Limited offer?
Alembic Pharmaceuticals Limited offers a wide range of products and services, including Women Care, Mother Care, Health Conditions, Fever, Hair Care, Hair Growth for Men, Vitamins & Supplements, Mineral Supplements, Specialty Supplements, Probiotics.
Who are the key members and board of directors at Alembic Pharmaceuticals?
Executive Team (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranav Amin  | Managing Director | 31-Mar-2011 | Current |
| Shaunak Amin | Managing Director | 02-May-2013 | Current |
| Chirayu Amin | CEO | 27-Apr-2016 | Current |
| R Baheti | CFO | 28-Jul-2014 | Current |
| Manisha Kathed | Company Secretary | 01-Apr-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Kejriwal | Director | 16-Apr-2024 | Current |
| Ashok Barat | Director | 10-Feb-2022 | Current |
| Archana Hingorani | Director | 04-Feb-2015 | Current |
| Chirayu Amin | Whole-Time Director and Ceo | 16-Jun-2010 | Current |
| Rajkumar Baheti | Whole-Time Director and Cfo | 16-Jun-2010 | Current |
| Jai Diwanji | Director | 05-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Alembic Pharmaceuticals.
Alembic Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.3% increase. The company also saw a substantial fall in profitability, with a 36.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alembic Pharmaceuticals?
In 2023, Alembic Pharmaceuticals had a promoter holding of 69.61% and a public holding of 30.40%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sbi Mutual Fund Trustee Company Private LimitedActive 21 years 11 monthsArchana Hingorani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jun 2011 | ₹600.00 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Nov 2021 | ₹5.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 26 Jul 2021 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Alembic Pharmaceuticals?
Alembic Pharmaceuticals has a workforce of 15263 employees as of Nov 12, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alembic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alembic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
